Protocol Ledger

NCT05248230 · Phase II · RECRUITING

4D-710 in Adult Patients With Cystic Fibrosis

Interventional Phase II clinical trial protocol NCT05248230 sponsored by 4D Molecular Therapeutics in Respiratory and Pulmonary, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2022-03-29 Enrollment: 30 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05248230
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)30 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05248230
Protocol FieldVerified Registry Value
NCT IdentifierNCT05248230
Consolidated Lead Sponsor4D Molecular Therapeutics
Therapeutic Condition CohortRespiratory and Pulmonary
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment30 participants (ESTIMATED)
Registered Start Date2022-03-29
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Respiratory and Pulmonary Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI